Table 3—

Insulin or sulfonylureas as a first-line therapy in type 2 diabetes

Other options
    Metformin (improved outcome?)
Or possibly:
    Thiazolidinediones (potential of β-cell preservation?)
    Acarbose (outcomes?)
    GLP-I analogs and DPP-IV inhibitors (potential of β-cell preservation?)